Skip to main content

Table 2 Effect of BV and BPF treatment on acrylamide and chips administration on the plasma GOT (U/ml), GPT (U/ml), and albumin (g/dl) for 60 day

From: Counter effect of bee venom and its extracted bradykinin-potentiating factor on acrylamide and chips administration-induced complications in the liver and kidney of male mice

 

Cont.

Acr.

Chip.

BV

BPF

Acr + BV

Acr + BPF

Chip + BV

Chip + BPF

GOT

Mean ± SE

94.9 ± 3.72

160.16 ± 3.29a**

178.4 ± 15.50a**

99.6 ± 9.74b**, c*

103.8 ± 9.14b**c*

110.9 ± 6.25b**, c*

103.5 ± 10.39b**, c*

103.8 ± 6.20b**, c*

106.6 ± 8.80b**, c*

% of change

1

+ 68.76

+ 87.98

+ 4.95

+ 9.37

+ 16.85

+ 9.06

+ 9.37

+ 12.32

2

+ 11.38

− 37.81

− 35.18

− 30.75

− 35.37

− 35.18

− 33.44

3

− 44.17

− 41.81

− 37.83

− 41.98

− 41.81

− 40.24

GPT

Mean ± SE

110.4 ± 6.73

178.6 ± 11.41a**

143.8 ± 4.35a*, b*

113 ± 7.43b*, c*

122.8 ± 4.58b*, c*

97.8 ± 8.97b**, c*

125 ± 4.53b*, c*

116.2 ± 7.61b*, c*

114.6 ± 7.11b*, c*

% of change

1

+ 61.7

+ 30.25

+ 2.35

+ 11.23

− 11.41

+ 13.22

+ 5.25

+ 3.80

2

− 19.48

− 36.73

− 31.24

− 45.24

− 30.01

−34.93

− 35.83

3

− 21.41

− 14.60

− 31.98

− 13.07

− 19.19

− 20.30

Albumin

Mean ± SE

3.696 ± 0.22

2.586 ± 0.036a*

2.968 ± 0.28

3.476 ± 0.09b**

3.606 ± 0.19b**

3.852 ± 0.11b**, c*

3.732 ± 0.138b**, c*

3.63 ± 0.21b*

3.82 ± 0.17b**, c*

% of change

1

− 30.08

− 19.78

− 5.95

− 2.43

+ 4.33

+ 1.08

− 1.62

3.52

2

+ 14.77

+ 34.41

+ 39.44

+ 48.95

+ 44.31

+ 40.37

+ 47.71

3

+ 17.11

+ 21.49

+ 29.78

+ 25.74

+ 22.30

+ 28.70

  1. Significance difference between control and treated groups. n = 5. % of change: (1) from control, (2) from acrylamide, (3) from chips
  2. *P < 0.05 significant, **P < 0.001 highly significant
  3. aSignificance difference to control
  4. bSignificance difference to acrylamide
  5. cSignificance difference to chips